Angiosoma, Inc
(832) 781-8521
719 Jadwin Ave, Richland, Washington, 99352
About us
AngioSoma (OTCQB:SOAN) is a clinical stage biotechnology company focused on improving the effectiveness of current standard-of-care treatments related to pharmaceutical or endovascular interventions. Our “end to end” solution will provide interventional radiologists, cardiologists, and internal medicine physicians with both pharmaceutical and or endovascular interventional options prior to infarction or critical limb ischemic events, stabilizing or reversing the atherosclerotic disease.
Website
https://angiosoma.com